Literature DB >> 10353787

Overgrowth of oral mucosa and facial skin, a novel feature of aspartylglucosaminuria.

P Arvio1, M Arvio, M Kero, S Pirinen, P L Lukinmaa.   

Abstract

Aspartylglucosaminuria (AGU) is a lysosomal storage disorder caused by deficiency of aspartylglucosaminidase (AGA). The main symptom is progressive mental retardation. A spectrum of different mutations has been reported in this disease, one missense mutation (Cys163Ser) being responsible for the majority of Finnish cases. We were able to examine 66 Finnish AGU patients for changes in the oral mucosa and 44 of these for changes in facial skin. Biopsy specimens of 16 oral lesions, 12 of them associated with the teeth, plus two facial lesions were studied histologically. Immunohistochemical staining for AGA was performed on 15 oral specimens. Skin was seborrhoeic in adolescent and adult patients, with erythema of the facial skin already common in childhood. Of 44 patients, nine (20%) had facial angiofibromas, tumours primarily occurring in association with tuberous sclerosis. Oedemic buccal mucosa (leucoedema) and gingival overgrowths were more frequent in AGU patients than in controls (p<0.001). Of 16 oral mucosal lesions studied histologically, 15 represented fibroepithelial or epithelial hyperplasias and were reactive in nature. Cytoplasmic vacuolisation was evident in four. Immunohistochemically, expression of AGA in AGU patients' mucosal lesions did not differ from that seen in corresponding lesions of normal subjects. Thus, the high frequency of mucosal overgrowth in AGU patients does not appear to be directly associated with lysosomal storage or with alterations in the level of AGA expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10353787      PMCID: PMC1734365     

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  30 in total

1.  Human leucocyte aspartylglucosaminidase. Evidence for two different subunits in a more complex native structure.

Authors:  R Halila; M Baumann; E Ikonen; N Enomaa; L Peltonen
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

2.  Spectrum of mutations in aspartylglucosaminuria.

Authors:  E Ikonen; P Aula; K Grön; O Tollersrud; R Halila; T Manninen; A C Syvänen; L Peltonen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

3.  An epidemiological study of rosacea.

Authors:  M Berg; S Lidén
Journal:  Acta Derm Venereol       Date:  1989       Impact factor: 4.437

4.  A topographical classification of the oral mucosa suitable for electronic data processing. Its application to 560 leukoplakias.

Authors:  B Roed-Petersen; G Renstrup
Journal:  Acta Odontol Scand       Date:  1969-12       Impact factor: 2.331

5.  Aspartylglycosaminuria in the Finnish population: identification of two point mutations in the heavy chain of glycoasparaginase.

Authors:  I Mononen; N Heisterkamp; V Kaartinen; J C Williams; J R Yates; P R Griffin; L E Hood; J Groffen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

6.  Oral fibromatosis in tuberous sclerosis.

Authors:  N A Lygidakis; R H Lindenbaum
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1989-12

7.  Impaired oral health in patients with aspartylglucosaminuria.

Authors:  P Arvio; M Arvio; J Wolf; P L Lukinmaa; L Saxen; S Pirinen
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1998-11

8.  Aspartylglycosaminuria in a non-Finnish patient caused by a donor splice mutation in the glycoasparaginase gene.

Authors:  I Mononen; N Heisterkamp; V Kaartinen; T Mononen; J C Williams; J Groffen
Journal:  J Biol Chem       Date:  1992-02-15       Impact factor: 5.157

9.  Abnormal collagen fibrils in aspartylglycosaminuria. Altered dermal ultrastructure in a glycoprotein storage disorder.

Authors:  K Näntö-Salonen; L J Pelliniemi; S Autio; T Kivimäki; J Rapola; R Penttinen
Journal:  Lab Invest       Date:  1984-10       Impact factor: 5.662

10.  Aspartylglucosaminuria: cDNA encoding human aspartylglucosaminidase and the missense mutation causing the disease.

Authors:  E Ikonen; M Baumann; K Grön; A C Syvänen; N Enomaa; R Halila; P Aula; L Peltonen
Journal:  EMBO J       Date:  1991-01       Impact factor: 11.598

View more
  4 in total

1.  Sleep disturbances in aspartylglucosaminuria (AGU): a questionnaire study.

Authors:  Niki Lindblom; Satu Kivinen; Hannu Heiskala; Maija-Liisa Laakso; Markus Kaski
Journal:  J Inherit Metab Dis       Date:  2006-08-30       Impact factor: 4.982

2.  Cetaceans evolution: insights from the genome sequences of common minke whales.

Authors:  Jung Youn Park; Yong-Rock An; Naohisa Kanda; Chul-Min An; Hye Suck An; Jung-Ha Kang; Eun Mi Kim; Du-Hae An; Hojin Jung; Myunghee Joung; Myung Hum Park; Sook Hee Yoon; Bo-Young Lee; Taeheon Lee; Kyu-Won Kim; Won Cheoul Park; Dong Hyun Shin; Young Sub Lee; Jaemin Kim; Woori Kwak; Hyeon Jeong Kim; Young-Jun Kwon; Sunjin Moon; Yuseob Kim; David W Burt; Seoae Cho; Heebal Kim
Journal:  BMC Genomics       Date:  2015-01-22       Impact factor: 3.969

Review 3.  Aspartylglycosaminuria: a review.

Authors:  Maria Arvio; Ilkka Mononen
Journal:  Orphanet J Rare Dis       Date:  2016-12-01       Impact factor: 4.123

4.  Biochemical characterization and comparison of aspartylglucosaminidases secreted in venom of the parasitoid wasps Asobara tabida and Leptopilina heterotoma.

Authors:  Quentin Coulette; Séverine Lemauf; Dominique Colinet; Geneviève Prévost; Caroline Anselme; Marylène Poirié; Jean-Luc Gatti
Journal:  PLoS One       Date:  2017-07-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.